GALECTIN THERAPEUTICS INC (GALT) has 150 open-market insider trades by 23 insiders since 2011. The most active filer is Kevin D. Freeman, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Richard E. Uihlein | Dir10% Owner | — | 5 | $40.6M | 2026-07-31 |
| James C. Czirr | 10% Owner | — | 13 | $9.8M | 2025-12-16 |
| Jack W. Callicutt | CFO | — | 9 | $5.1M | 2026-01-06 |
| 10X Capital Management, LLC via James C. Czirr | 10% Owner | — | 7 | $3.4M | 2025-12-03 |
| 10X Fund, L.P. via James C. Czirr | 10% Owner | — | 7 | $3.2M | 2022-07-27 |
| Rod D. Martin | Dir | — | 3 | $2.8M | 2015-04-08 |
| Harold H. Shlevin | Dir | — | 7 | $2.2M | 2026-06-29 |
| Peter G. Traber | CEOPres | — | 13 | $1.2M | 2018-06-13 |
| Marc Rubin | Dir | — | 6 | $1.0M | 2019-02-22 |
| Joel Lewis | CEOPres | — | 8 | $456K | 2026-01-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Khurram Jamil | — | Sell | $83K | 2026-07-14 |
| Harold H. Shlevin | Director | Sell | $151K | 2026-06-26 |
| Khurram Jamil | — | Sell | $262K | 2026-06-26 |
| Khurram Jamil | — | Sell | $24K | 2026-06-23 |
| Khurram Jamil | — | Sell | $2K | 2026-05-26 |
| Kary Eldred | Director | Buy | $810 | 2026-02-06 |
Companies that share insiders with GALT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Khurram Jamil | — | Sell | $232K | 2026-01-02 |
| Jack W. Callicutt | CFO | Sell | $233K | 2026-01-02 |
| Joel Lewis | CEO & President | Sell | $321K | 2026-01-02 |
| Khurram Jamil | Chief Medical Officer | Sell | $33K | 2025-12-31 |
| Kevin D. Freeman | Director | Buy | $20K | 2025-12-23 |
| Kary Eldred | Director | Buy | $3K | 2025-12-23 |
| Khurram Jamil | — | Sell | $137K | 2025-12-17 |
| Joel Lewis | CEO & President | Sell | $111K | 2025-12-17 |
| Harold H. Shlevin | Director | Sell | $312K | 2025-12-17 |